We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Virtus LifeSci Biotech Clinical Trials ETF | AMEX:BBC | AMEX | Exchange Traded Fund |
Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.0092 | 0.04% | 21.8292 | 21.985 | 21.74 | 21.93 | 3,936 | 21:15:00 |
RNS Number:7895Q Ben Bailey PLC 10 October 2003 SCHEDULE 11 NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS 1) NAME OF COMPANY BEN BAILEY PLC 2) NAME OF DIRECTOR STEPHEN W NORTH 3) Please state whether notification indicates that it is in respect of holding of the shareholder named in 2 above or in respect of a non-beneficial interest or in the case of an individual holder if it is a holding of that person's spouse or children under the age of 18 or in respect of an non-beneficial interest AS 2 ABOVE 4) Name of the registered holder(s) and, if more than one holder, the number of shares held by each of them. (If notified) AS 2 ABOVE 5) Please state whether notification relates to a person(s) connected with the Director named in 2 above and identify the connected person(s) N/A 6) Please state the nature of the transaction. For PEP transactions please indicate whether general/single co PEP and if discretionary/non discretionary SALE OF ORDINARY SHARES 7) Number of shares/amount of stock acquired 8) Percentage of issued Class - 9) Number of shares/amount of stock disposed 6,000 10) Percentage of issued Class 0.052% 11) Class of security N/A 12) Price per share 389p 13) Date of transaction 10/10/03 14) Date company informed 10/10/03 15) Total holding following this notification 0% 16) Total percentage holding of issued class following this notification 0% IF A DIRECTOR HAS BEEN GRANTED OPTIONS BY THE COMPANY PLEASE COMPLETE THE FOLLOWING BOXES 17) Date of grant 18) Period during which or date on which exercisable 19) Total amount paid (if any) for grant of the option 20) Description of shares or debentures involved: class, number. 21) Exercise price (if fixed at time of grant) or indication that price is to be fixed at time of exercise 22) Total number of shares or debentures over which options held following this notification 23) Any additional information 24) Name of contact and telephone number for queries AS 2 ABOVE 01709 586 261 25) Name and signature of authorised company official responsible for making this notification S W NORTH Date of Notification 10TH OCTOBER 2003 This information is provided by RNS The company news service from the London Stock Exchange END RDSUROSROURRAAA
1 Year Virtus LifeSci Biotech C... Chart |
1 Month Virtus LifeSci Biotech C... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions